Theobroma Labs

Theobroma Labs is a biotechnology company primarily known for its development of theobromine-based pharmaceutical products for respiratory health. The company's lead program, BC1036, is a small molecule antitussive derived from the cacao plant, designed to treat persistent cough by inhibiting the sensory nerve activation of the vagus nerve. Unlike traditional cough suppressants like codeine, theobromine is non-opioid and has demonstrated a favorable safety profile in clinical trials. The company was originally established as a subsidiary of the Seek Group (formerly Helios Bioscience) to commercialize research from Imperial College London. While the clinical development of theobromine for cough continues under the parent organization, Theobroma Labs also maintains a presence in the consumer health market, offering theobromine as a dietary supplement for energy and focus.